ABT-263

navitoclax · Abbott Laboratories

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ABT-263, covering 2010-02-26 to 2023-06-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 1, Phase 2]